Wegovy and Ozempic linked to reduced incidence and recurrence of alcohol abuse or dependence, study suggests

FHS
June 14, 2024
11:24 am

Researchers investigated the potential therapeutic benefits of semaglutide for alcohol use disorders.

Pfizer touts bladder cancer results as first advancement for some patients ‘in decades’

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

January 11, 2025

CDC Reports Deaths After Medical Tourism in the Dominican Republic

There were 93 deaths among U.S. residents who traveled to the Dominican Republic (D.R.) for cosmetic surgery from 2009 through 2022, according to findings in

January 26, 2024

AusperBio’s AHB-137 breakthrough designation in China for CHB

AHB-137 is a new therapeutic option for patients with chronic hepatitis B. Credit: Peakstock/Shutterstock. AusperBio Therapeutics and Ausper Biopharma have gained breakthrough therapy designation (BTD)

July 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.